Gablofen
Payments companies reported to CMS as associated with Gablofen. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Gablofen, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Gablofen
These are the largest totals companies reported as associated with Gablofen. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Zachary Bohart | Burlington, MA | Physical Medicine & Rehabilitation | $357,222.04 |
| Christopher Cronsell | Milwaukee, WI | Physical Medicine & Rehabilitation | $135,474.56 |
| Ravi Kasi | Chicago, IL | Physical Medicine & Rehabilitation | $67,286.68 |
| Monica Verduzco-Gutierrez | San Antonio, TX | Brain Injury Medicine (Physical Medicine & Rehabilitation) | $60,864.24 |
| Elizabeth Moberg Wolff | Wauwatosa, WI | Pediatric Rehabilitation Medicine | $60,165.68 |
| Jose Urquidez | Austin, TX | Physical Medicine & Rehabilitation | $50,205.04 |
| Robert Friedman | Boise, ID | Physical Medicine & Rehabilitation | $44,062.44 |
| Andrea Toomer | Marrero, LA | Physical Medicine & Rehabilitation | $36,640.80 |
| Lizette Alvarez | Saint Louis, MO | Physical Medicine & Rehabilitation | $31,185.76 |
| Bryan Le | Bronx, NY | Physical Medicine & Rehabilitation | $21,439.92 |
Prescribed Gablofen?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.